Less FVC Decline in Progressive PF With Oral Nerandomilast ...Middle East

Medscape - News
Less FVC Decline in Progressive PF With Oral Nerandomilast
The investigative phosphodiesterase 4B inhibitor appears better than placebo at protecting against decline in lung function over 1 year. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Less FVC Decline in Progressive PF With Oral Nerandomilast )

Apple Storegoogle play

Also on site :